Details of the Drug
General Information of Drug (ID: DMP5VZQ)
| Drug Name |
Anti-FGFR1 mab program
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Anti-FGFR1 mAb program (cancer); Anti-FGFR1 mAb program (cancer), AVEO Pharmaceuticals; Anti-fibroblast growth factor receptor-1 monoclonal antibody program (cancer), AVEO Pharmaceuticals | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Antibody
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Solid tumour/cancer | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | 2A00-2F9Z | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||

